Amrize Ltd (NYSE:AMRZ) Stock Has Consensus Price Target of $50.00 According to Brokerages

Amrize Ltd (NYSE:AMRZ – Get Free Report) has earned an average rating of “Hold” from the twenty research firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $50.00.

AMRZ has been the subject of a number of research analyst reports. Wells Fargo & Company decreased their price objective on shares of Amrize from $44.00 to $40.00 and set an “equal weight” rating for the company in a report on Monday, October 5th. Longbow Research initiated coverage on shares of Amrize in a research note on Monday, October 12th. They issued a “buy” rating on the stock. DA Davidson set a $40.00 target price on shares of Amrize in a research report on Friday, October 9th. Bank of America reaffirmed an “underperform” rating and set a $40.00 price target (down from $50.00) on shares of Amrize in a research note on Wednesday, September 2nd. Finally, UBS Group lowered their price target on Amrize from $57.00 to $42.00 and set a “neutral” rating for the company in a report on Tuesday, September 22nd.

Check Out Our Latest Research Report on AMRZ

Insider Activity at Amrize

In other Amrize news, CFO Baris Oran purchased 3,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was bought at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the purchase, the chief financial officer owned 3,000 shares in the company, valued at $142,140. This represents a ? increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jan Jenisch bought 4,000 shares of the company’s stock in a transaction on Wednesday, September 2nd. The shares were bought at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the transaction, the chief executive officer owned 519,000 shares in the company, valued at $22,057,500. The trade was a 0.78% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased 48,983 shares of company stock valued at $2,158,755 over the last 90 days. Company insiders own 0.54% of the company’s stock.

Institutional Trading of Amrize

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. National Pension Service grew its stake in Amrize by 7.5% during the 2nd quarter. National Pension Service now owns 1,493,022 shares of the company’s stock valued at $79,578,000 after acquiring an additional 103,962 shares in the last quarter. Ancora Advisors LLC boosted its holdings in shares of Amrize by 22.9% during the 2nd quarter. Ancora Advisors LLC now owns 283,522 shares of the company’s stock worth $15,112,000 after purchasing an additional 52,759 shares during the last quarter. Engle Capital Management L.P. acquired a new position in shares of Amrize during the 1st quarter worth approximately $3,742,000. Renaissance Technologies LLC grew its position in shares of Amrize by 10.4% in the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after purchasing an additional 183,900 shares in the last quarter. Finally, Punch & Associates Investment Management Inc. purchased a new stake in shares of Amrize in the first quarter valued at approximately $8,864,000.

Amrize Price Performance

Shares of AMRZ stock traded up $0.54 on Friday, reaching $37.85. The company’s stock had a trading volume of 4,542,880 shares, compared to its average volume of 3,589,370. The stock’s fifty day simple moving average is $40.94 and its 200-day simple moving average is $48.83. Amrize has a 1 year low of $35.78 and a 1 year high of $65.94. The company has a market capitalization of $20.94 billion, a price-to-earnings ratio of 17.44, a price-to-earnings-growth ratio of 1.32 and a beta of 0.20. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The company had revenue of $3.49 billion for the quarter. Analysts forecast that Amrize will post 2.44 earnings per share for the current fiscal year.

Amrize Announces Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s payout ratio is 5.07%.

Amrize Company Profile

(Get Free Report)

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.

Featured Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.